Snijders PJ, Steenbergen RD, Heideman DA, Meijer CJ (2006). «HPV-mediated cervical carcinogenesis: Concepts and clinical implications». J. Pathol. 208 (2): 152-64. doi:10.1002/path.1866. PMID 16362994.
D’Souza G, Kreimer AR, Viscidi R, et al. (May 2007). «Case-control study of human papillomavirus and oropharyngeal
cancer». The New England journal of medicine 356 (19): 1944-56. doi:10.1056/NEJMoa065497. PMID 17494927.
Lowy DR, Schiller JT (May 2006). «Prophylactic human papillomavirus vaccines». The Journal of clinical investigation 116 (5): 1167-73. doi:10.1172/JCI28607. PMID 16670757.
Cottler L, Garvin EC, Callahan C (September 2006). «Condom use and the risk of HPV infection». The New England journal of medicine 355 (13): 1388-9; author reply 1389. doi:10.1056/NEJMc061933. PMID 17014039.
McNeil C (April 2006). «Who invented the VLP cervical cancer vaccines?».Journal of the National Cancer Institute 98
(7):433. doi:10.1093/jnci/djj144. PMID 16595773.
Muñoz N, Bosch FX, Castellsagué X, Díaz M, de Sanjose S, Hammouda D, Shah KV, Meijer CJ (2004-08-20). «Against which human papillomavirus types shall we vaccinate and screen? The international perspective.». Int J Cancer 111 (2): 278-85. doi:10.1002/ijc.20244. PMID 15197783.
Roden RB, Ling M, Wu TC (August 2004). «Vaccination to prevent and treat cervical cancer». Human pathology 35 (8): 971-82. doi:10.1016/j.humpath.2004.04.007. PMID 15297964.
Rosenthal, Elisabeth (2008-08-19). «Drug Makers’ Push Leads to Cancer Vaccines’ Fast Rise». The New York Times. [2]Архивная копия от 9 апреля 2009 на Wayback Machine
Rosenthal, Elisabeth (2008-08-19). «Drug Makers’ Push Leads to Cancer Vaccines’ Fast Rise». The New York Times. [2]Архивная копия от 9 апреля 2009 на Wayback Machine
